Low-dose radiation for juxtapapillary choroidal melanoma shows promising outcomes and safety

low-dose-radiation-for-juxtapapillary-choroidal-melanoma-shows-promising-outcomes-and-safety.jpg

MAR 14, 2018

Ocular Pathology/Oncology


This retrospective case series examined outcomes of patients undergoing iodine-125 plaque brachytherapy for juxtapapillary choroidal melanoma.

Study design

The analysis included 47 patients with juxtapapillary choroidal melanoma treated with iodine-125 notched brachytherapy at a single center. The cohort was divided into apex low-dose (≤84.35 Gy) and high-dose (>85.35 Gy) groups.

Main outcome measures were time to distant failure, local failure, death, enucleation, radiation retinopathy, optic neuropathy and best corrected visual acuity.

Outcomes

Low-dose iodine-125 plaque brachytherapy (67.5–81 Gy at tumor apex) provided distant failure, local failure, death and enucleation rates comparable with those observed in the high-dose group. The authors demonstrated that there are potentially superior outcomes in terms of reduced radiation retinopathy and optic neuropathy for lower dose brachytherapy.

Limitations

Patients in this study were treated in 1 center and the results may not represent all institutions. The study was also limited by its retrospective nature and small sample size. Finally, the analysis was performed prior to routine fine needle aspiration biopsy for genetic profiling—thus, the authors were unable to examine the correlation between genetic mutations and patient outcomes.

Clinical significance

This was the first study to demonstrate that survival and tumor control are not compromised by low-dose brachytherapy. The low-dose group had similar 5-year tumor control rates as patients with juxtapapillary melanoma in the COMS (Collaborative Ocular Melanoma Study) trial.  A multi-institutional study would provide more insight into dose recommendations for juxtapapillary choroidal melanoma.

View Abstract American Journal of Ophthalmology, February 2018

https://www.aao.org/editors-choice/low-dose-radiation-juxtapapillary-choroidal-melano

Comments

Post a Comment

Popular posts from this blog

I Spy a Stye in Your Eye

Image
Written by Dr. David Evans Last modified on August 6, 2018 What’s that small, red, pimple-like bump on your eyelid that’s causing so much discomfort? It’s probably a stye (sometimes referred to as a sty or hordeolum). Besides being difficult to say 5 times quickly, an eye stye is a type of localized infection that can occur along the base of your eyelashes or underneath your eyelid. Styes that form along the base of the eyelashes are called external styes. They typically occur as a result of an infected eyelash hair follicle and look like the type of pimple that occurs when your pores are clogged with dirt and oil. Styes that form inside the eyelid are called internal styes. Similar to external styes, they are caused by an infection of an oil-producing gland behind the eyelid rather than an eyelash hair follicle. Internal styes result in generalized swelling of the eyelid rather than forming a pimple-like bump. Stye Symptoms As a stye develops, you might begin to experience pain
Read more

Post-LASIK Refraction and Pregnancy – Much Ado About Nothing?

Image
Written by Dr. David Evans Last modified on August 23, 2018 During pregnancy, women experience a drastic shift in their hormonal balance that has a ripple effect throughout the body. The spike in hormones like progesterone, estrogen, prolactin, oxytocin and relaxin are all important for a healthy pregnancy, but these increased levels can also impact gastrointestinal processes, blood pressure, skin pigmentation and, you guessed it, ocular health. Due to refractive changes that often occur during pregnancy, most refractive surgeons advise against LASIK during pregnancy, instead suggesting women wait several months after giving birth before considering treatment. Women who have already undergone LASIK may then wonder if the changes in ocular health that can occur during and after pregnancy impact post-LASIK refraction. New research presented by John Kanellopoulos, MD, New York University Medical School, NY, and LaserVision.gr seems to throw cold water on any such concern. The Eyes an
Read more